Absea

Absea delivers innovative solutions for proteomics and interactomics, empowering scientific research and industrial applications. With an extensive global presence—featuring their Innovation Centre in Berlin, Manufacturing Centres in China, and a Commercialisation Centre in the Bay Area—Absea supports protein scientists and industry leaders advancing AI-driven protein design, diagnostics, and drug development.

Their product portfolio includes a comprehensive library of over 13,000 soluble proteins, representing 65% of the human proteome, with ongoing expansion of their synthetic proteome portfolio. Additionally, they provide a collection of more than 7,000 monoclonal antibodies, meticulously validated for a wide range of applications. These resources make Absea an invaluable partner in pushing the boundaries of proteomic and therapeutic innovation.

Contact our Absea specialists to learn more about the portfolio.